MedPath

Alio, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
3 (100.0%)

Alio WEAR Study: Long-term Wear of the Alio Platform

Not Applicable
Recruiting
Conditions
End Stage Kidney Disease
First Posted Date
2023-09-28
Last Posted Date
2023-10-11
Lead Sponsor
Alio, Inc.
Target Recruit Count
250
Registration Number
NCT06056739
Locations
πŸ‡ΊπŸ‡Έ

Site 1, Huntley, Illinois, United States

The Jordan Study for End-Stage Renal Disease Subjects

Not Applicable
Recruiting
Conditions
End Stage Renal Disease
First Posted Date
2022-05-19
Last Posted Date
2024-06-21
Lead Sponsor
Alio, Inc.
Target Recruit Count
75
Registration Number
NCT05382663
Locations
πŸ‡―πŸ‡΄

Jordan Center for Pharmaceutical Research, Amman, Jordan

The ReModel IHC Study for ESRD Patients

Not Applicable
Completed
Conditions
Dialysis Access Malfunction
First Posted Date
2021-09-09
Last Posted Date
2023-09-22
Lead Sponsor
Alio, Inc.
Target Recruit Count
12
Registration Number
NCT05039541
Locations
πŸ‡ΊπŸ‡Έ

Intermountain Dialysis, Murray, Utah, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.